MHRA Revised Guidance on Clinical Investigations: Overview
The article provides a general overview of the UK regulatory framework for clinical investigations related to medical devices intended to be marketed and used in the country.
The article provides a general overview of the UK regulatory framework for clinical investigations related to medical devices intended to be marketed and used in the country.
The new article elaborates further on the aspects related to risk management in the context of medical devices to be used in the course of clinical investigations.
The new article clarifies the aspects related to the pre-clinical evaluation the device should undergo before it will be allowed for use in patients.
The new article describes in detail the approach to be applied with respect to labeling for medical devices undergoing clinical evaluation.
The article highlights the key points related to the information the Investigator’s Brochure should contain in order to meet the relevant regulatory requirements.